Glucagon-like peptide-1 and energy homeostasis

被引:39
|
作者
Burcelin, Remy [1 ]
Cani, Patrice D.
Knauf, Claude
机构
[1] Univ Toulouse 3, Inst Mol Med Rangueil I2MR, INSERM 858, IFR 31,CHU Rangueil, F-31432 Toulouse 4, France
[2] Catholic Univ Louvain, Unit Pharmacokinet Metab Nutr & Toxicol, B-1200 Brussels, Belgium
来源
JOURNAL OF NUTRITION | 2007年 / 137卷 / 11期
关键词
D O I
10.1093/jn/137.11.2534S
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
A growing body of evidence demonstrates the role of gut-derived hormones in the control of energy homeostasis. Among those intestinal signals, physiological and therapeutic interest has been drawn to glucagon-like peptide-1 (GLP-1). The main reasons are that this hormone 1) is secreted by epithelial intestinal L-cells in response to glucose and lipids, 2) enhances glucose-stimulated insulin secretion, 3) improves blood glucose profiles of type 2 diabetic patients by means of several actions on pancreatic hormone secretions, 4) reduces body weight and food intake, and 5) slows gastric emptying. Furthermore, recent evidence has suggested that the nervous system is a key player accounting for the beneficial role of GLP-l on the control of energy homeostasis. Hence, the role of GLP-1 on the gut-to-brain axis is reviewed.
引用
收藏
页码:2534S / 2538S
页数:5
相关论文
共 50 条
  • [41] Differentiation of glucagon and glucagon-like peptide-1 effects on hepatocytes
    Wang, Xiaozhen
    Conway, James
    Beaton, Michelle
    De Los Reyes, Melissa
    Raja, Rajiv
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E552 - E552
  • [42] Glucagon-like peptide-1 drives energy metabolism on the synaptic highway
    Liu, Ji
    Pang, Zhiping P.
    FEBS JOURNAL, 2016, 283 (24) : 4413 - 4423
  • [43] Influence of glucagon-like peptide 2 on energy homeostasis
    Baldassano, Sara
    Amato, Antonella
    Mule, Flavia
    PEPTIDES, 2016, 86 : 1 - 5
  • [44] The effect of glucagon-like peptide-1 and glucagon-like peptide-2 on microcirculation: A systematic review
    Nerup, Nikolaj
    Ambrus, Rikard
    Lindhe, Joanna
    Achiam, Michael P.
    Jeppesen, Palle B.
    Svendsen, Lars B.
    MICROCIRCULATION, 2019, 26 (03)
  • [45] Can epicardial fat glucagon-like peptide-1 receptor open up to the cardiovascular benefits of glucagon-like peptide-1 analogues?
    Iacobellis, Gianluca
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2021, 131 (03): : 224 - 225
  • [46] Effects of gastric inhibitory polypeptide, glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists on Bone Cell Metabolism
    Hansen, Morten S. S.
    Tencerova, Michaela
    Frolich, Jacob
    Kassem, Moustapha
    Frost, Morten
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 122 (01) : 25 - 37
  • [47] Insulin resistance, glucagon-like peptide-1 and factors influencing glucose homeostasis in neonates
    Salis, Emma R.
    Reith, David M.
    Wheeler, Benjamin J.
    Broadbent, Roland S.
    Medlicott, Natalie J.
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2017, 102 (02): : F162 - F166
  • [48] Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors
    Vishnoi, Shubham
    Bhattacharya, Shayon
    Walsh, Erica M.
    Okoh, Grace Ilevbare
    Thompson, Damien
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2023, 63 (15) : 4934 - 4947
  • [49] GLUCAGON-LIKE PEPTIDE-1 IS A PHYSIOLOGICAL INCRETIN IN RAT
    WANG, ZL
    WANG, RM
    OWJI, AA
    SMITH, DM
    GHATEI, MA
    BLOOM, SR
    JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (01): : 417 - 421
  • [50] Equine glucagon-like peptide-1 receptor physiology
    Kheder, Murad H.
    Bailey, Simon R.
    Dudley, Kevin J.
    Sillence, Martin N.
    de Laat, Melody A.
    PEERJ, 2018, 6